Tirzepatide vs semaglutide for asthma: the difference was smaller than researchers expected
Researchers compared two widely used incretin therapies in more than 16,000 matched adults with asthma and type 2…
Psilocybin protects sensory nerves from chemotherapy damage in preclinical study
From mouse models to freshly isolated human nerves, researchers traced what happens when chemotherapy disrupts the cellular machinery…
Semaglutide slows blood protein signature linked to future dementia risk
In older adults with cardiovascular disease and overweight or obesity, semaglutide slowed worsening of a blood-based dementia risk…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
People judge GLP-1 users more harshly than dieters
Even as GLP-1 medications transform obesity treatment, new research reveals a surprising reality: people may face stigma whether…
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
UCLA Health finds eco-friendly inhalers improve COPD outcomes
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are…
Short-duration psychedelic therapy shows promise for major depression treatment
A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
Stopping GLP-1 drugs before pregnancy leads to more weight gain
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
Searches for “Ozempic face” surge as people look for filler-based solutions
New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…